Current dermatological guidelines now recognize crisaborole two percent ointment as a potential first-line treatment option ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Read the entire package insert before using this ...

According to newly published research, the exposure to nature provided by the Re-Connecting Nature forest microbe extract has ...

Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profile Data includes complete results from ...

The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-sev ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Organon's VTAMA (tapinarof) cream is a first-in-class therapy with new FDA approval for atopic dermatitis in adults and children aged 2 and older.

Monday announced that the U.S. Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream, an aryl ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

The approval was based on data from 2 multicenter, randomized, double-blind, vehicle-controlled trials, ADORING 1 and ADORING 2.